These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 9855358

  • 1. Different time courses of recovery after poisoning with botulinum neurotoxin serotypes A and E in humans.
    Eleopra R, Tugnoli V, Rossetto O, De Grandis D, Montecucco C.
    Neurosci Lett; 1998 Nov 13; 256(3):135-8. PubMed ID: 9855358
    [Abstract] [Full Text] [Related]

  • 2. Botulinum neurotoxin serotypes A and C do not affect motor units survival in humans: an electrophysiological study by motor units counting.
    Eleopra R, Tugnoli V, Quatrale R, Gastaldo E, Rossetto O, De Grandis D, Montecucco C.
    Clin Neurophysiol; 2002 Aug 13; 113(8):1258-64. PubMed ID: 12140005
    [Abstract] [Full Text] [Related]

  • 3. Enhanced Effect of Botulinum Toxin A Injections into the Extensor Digitorum Brevis Muscle after Local Mechanical Leg Vibration: A Case Report.
    Hefter H, Beek J, Rosenthal D, Samadzadeh S.
    Toxins (Basel); 2021 Jun 15; 13(6):. PubMed ID: 34203875
    [Abstract] [Full Text] [Related]

  • 4. Botulinum neurotoxin serotype D - A potential treatment alternative for BoNT/A and B non-responding patients.
    Kutschenko A, Weisemann J, Kollewe K, Fiedler T, Alvermann S, Böselt S, Escher C, Garde N, Gingele S, Kaehler SB, Karatschai R, Krüger THC, Sikorra S, Tacik P, Wegner F, Wollmann J, Bigalke H, Wohlfarth K, Rummel A.
    Clin Neurophysiol; 2019 Jun 15; 130(6):1066-1073. PubMed ID: 30871800
    [Abstract] [Full Text] [Related]

  • 5. Neuromuscular paralysis and recovery in mice injected with botulinum neurotoxins A and C.
    Morbiato L, Carli L, Johnson EA, Montecucco C, Molgó J, Rossetto O.
    Eur J Neurosci; 2007 May 15; 25(9):2697-704. PubMed ID: 17561839
    [Abstract] [Full Text] [Related]

  • 6. Responsiveness to botulinum toxin type A in muscles of complex regional pain patients with tonic dystonia.
    Schilder JC, van Dijk JG, Dressler D, Koelman JH, Marinus J, van Hilten JJ.
    J Neural Transm (Vienna); 2014 Jul 15; 121(7):761-7. PubMed ID: 24532257
    [Abstract] [Full Text] [Related]

  • 7. Persistence of botulinum neurotoxin A demonstrated by sequential administration of serotypes A and E in rat EDL muscle.
    Adler M, Keller JE, Sheridan RE, Deshpande SS.
    Toxicon; 2001 Jul 15; 39(2-3):233-43. PubMed ID: 10978741
    [Abstract] [Full Text] [Related]

  • 8. Different types of botulinum toxin in humans.
    Eleopra R, Tugnoli V, Quatrale R, Rossetto O, Montecucco C.
    Mov Disord; 2004 Mar 15; 19 Suppl 8():S53-9. PubMed ID: 15027055
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. British Neurotoxin Network recommendations for managing cervical dystonia in patients with a poor response to botulinum toxin.
    Marion MH, Humberstone M, Grunewald R, Wimalaratna S.
    Pract Neurol; 2016 Aug 15; 16(4):288-95. PubMed ID: 26976927
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of short-term electrical stimulation before and after botulinum toxin injection.
    Santus G, Faletti S, Bordanzi I, Pirali F, De Grandis D.
    J Rehabil Med; 2011 Apr 15; 43(5):420-3. PubMed ID: 21448556
    [Abstract] [Full Text] [Related]

  • 13. How muscles recover from paresis and atrophy after intramuscular injection of botulinum toxin A: Study in juvenile rats.
    Shen J, Ma J, Lee C, Smith BP, Smith TL, Tan KH, Koman LA.
    J Orthop Res; 2006 May 15; 24(5):1128-35. PubMed ID: 16602109
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Serial neurophysiological studies of intramuscular botulinum-A toxin in humans.
    Hamjian JA, Walker FO.
    Muscle Nerve; 1994 Dec 15; 17(12):1385-92. PubMed ID: 7969239
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Presynaptic protein interactions in vivo: evidence from botulinum A, C, D and E action at frog neuromuscular junction.
    Raciborska DA, Trimble WS, Charlton MP.
    Eur J Neurosci; 1998 Aug 15; 10(8):2617-28. PubMed ID: 9767392
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.